JAK2 and essential thrombocythemia: Finally, there is no expression data for the intermediate cells between the BM CD34 + stem cells and the PB neutrophils or PBMCs, as the only available datasets in GEO that include transcriptomic data from ET patients with CALR or JAK2 mutations are those used in this study.